Preparation for online psychological therapy for depression in people living with and beyond cancer in East Midlands NHS primary and secondary care services in England: protocol for the PROSPER randomised controlled trial
Open Access
Abstract
Introduction: Depression is up to four times more common among individuals with cancer compared with the general population. Psychological therapies are effective in treating depression among patients in cancer care, but access is often delayed, which can exacerbate symptoms, increase dropout and reduce therapeutic effectiveness. This study evaluates the clinical and cost-effectiveness of a therapy preparation intervention (TPI) designed to enhance engagement and outcomes among patients awaiting psychological therapy in cancer care. Methods and analysis: This study is a parallel-group, two-arm, multicentre, single-blind randomised controlled trial. A total of 150 adults (=18 years) living with or beyond cancer and experiencing moderate-to-severe depression will be recruited from health services in the East Midlands region of England. Participants will be randomised (1:1) to receive either TPI plus treatment as usual (TAU) or TAU alone. The primary outcome is depression severity measured using the Patient Health Questionnaire 9-items (PHQ-9) over a 24-week follow-up. Secondary outcomes include anxiety, functioning, mental well-being, patient activation, readiness for change, health-related quality of life and health economics, and therapy engagement including attendance and dropout. Hope and in-session patient activation, assessed using recorded treatment preparation sessions, will be explored as additional mechanistic variables. Health economic outcomes will be assessed at baseline and 24 weeks. Data will be collected via online or telephone surveys at baseline, and at 4, 8, 12 and 24 weeks post randomisation. Qualitative interviews with a subset of participants will explore intervention experiences, analysed using reflexive thematic analysis. Ethics and dissemination: Ethical approval has been obtained from the Health Research Authority and National Health Service Research Ethics Committee (Bromley) (REC reference: 24/LO/0610). Findings will be disseminated through peer-reviewed journals, academic conferences and clinical and patient networks. Trial registration number: ISRCTN registry: NCT13692666 , registered on 18 October 2024.Keywords
Funding Information
- East Midlands Cancer Alliance (Not applicable)
- NIHR ARC East Midlands (Not applicable)
This publication has 39 references indexed in Scilit:
- Doing Reflexive Thematic Analysis2022
- Using smart‐messaging to enhance mindfulness‐based cognitive therapy for cancer patients: A mixed methods proof of concept evaluationPsycho-Oncology, 2019
- Risk of Suicide After Cancer Diagnosis in EnglandJAMA Psychiatry, 2019
- The impact of waiting time on patient outcomes: Evidence from early intervention in psychosis services in EnglandHealth Economics, 2018
- Evaluating and establishing national norms for mental wellbeing using the short Warwick–Edinburgh Mental Well-being Scale (SWEMWBS): findings from the Health Survey for EnglandQuality of Life Research, 2016
- The Effects of Waiting for Treatment: A Meta‐Analysis of Waitlist Control Groups in Randomized Controlled Trials for Social Anxiety DisorderClinical Psychology & Psychotherapy, 2016
- Impact of Depression on Treatment Adherence and Survival from Cancer2010
- Preparing Clients for Cognitive Behavioral Therapy: A Randomized Pilot Study of Motivational Interviewing for AnxietyCognitive Therapy and Research, 2006
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Factor structure of the Beck Hopelessness ScaleJournal of Clinical Psychology, 1996